MedPath

Plant-Based Dietary Intervention in Type 2 Diabetes

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Behavioral: Low-fat, low-Glycemic Index, vegan diet
Registration Number
NCT00276939
Lead Sponsor
Physicians Committee for Responsible Medicine
Brief Summary

The purpose of the study is to assess whether, in individuals with type 2 diabetes, a low-fat, vegan diet improves blood glucose control more effectively than a control diet based on current American Diabetes Association (ADA) guidelines. The principal measure is hemoglobin A1c. Cardiovascular risk factors and dietary acceptability are also assessed. The study duration is 22 weeks with a one-year follow-up.

Detailed Description

Preliminary evidence suggests that low-fat, vegetarian regimens similar to those used to reverse coronary artery blockages may have a significant beneficial effect on type 2 diabetes, as demonstrated by reductions in fasting serum glucose concentrations and medication use. We therefore randomly assigned 99 individuals with type 2 diabetes to either a low-fat, vegan diet or a diet based on current American Diabetes Association guidelines for 22 weeks with a one-year follow-up period. The principal dependent measure is hemoglobin A1c. Cardiovascular risk factors are also being tracked, as is dietary acceptance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
99
Inclusion Criteria
  • Diagnosis of Type 2 Diabetes Mellitus
Exclusion Criteria
  • hemoglobin A1c values <6.5% or >10.5%
  • use of insulin for > 5 years
  • tobacco use within the preceding 6 months
  • consumption of more than 2 alcoholic beverages per day
  • current drug abuse
  • pregnancy
  • unstable medical status
  • current use of a low-fat, vegetarian diet.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Low-fat, low-Glycemic Index, vegan dietLow-fat, low-Glycemic Index, vegan diet
2Low-fat, low-Glycemic Index, vegan dietADA diet
Primary Outcome Measures
NameTimeMethod
Hemoglobin A1c22 weeks
Secondary Outcome Measures
NameTimeMethod
Body weight22 weeks
Plasma lipid concentrations22 weeks
Urinary albumin22 weeks
Dietary Acceptability22 weeks

Trial Locations

Locations (1)

Physicians Committee for Responsible Medicine

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath